We searched the scientific literature and other data sources regarding global diabetes incidence for articles that we judged to be important and timely contributions to the topics addressed in this Review. Our reference list was modified on the basis of comments from peer reviewers.
ReviewDiabetes: a 21st century challenge
Introduction
Lifestyle changes and globalisation have, during the past five decades, resulted in remarkable changes in societies, political systems, the environment, and human behaviour. The number of people with diabetes and obesity has increased substantially in both developed and developing countries,1, 2 with the greatest burden tending to fall on socially disadvantaged groups and Indigenous peoples. Diabetes ranks highly on the international health agenda as a global pandemic and as a threat to human health and global economies,2 and has been termed “the diabetes apocalypse” by Edwin Gale (Gale E, University of Bristol, personal communication).
In 1971, when Bennett and colleagues3 reported the very high prevalence of diabetes in the American Pima Indians (50% for adults older than 35 years), who could have predicted that this was the harbinger of a worldwide diabetes epidemic? Yet, diabetes (predominantly type 2 diabetes), long thought of as a Cinderella disease, has become a major health challenge of the 21st century, together with other non-communicable diseases such as cardiovascular disease.4
After Bennett and colleagues' report,3 other similar data started to emerge. In 1975, it was reported5 that the central Pacific island of Nauru had a national diabetes prevalence of more than 34% in people aged 15 years or older—the highest national prevalence of any country, both at that time and at present. This Micronesian population had become almost totally westernised,6 or, as Arthur Koestler7 aptly described, had undergone “Coca-colonisation”. In the case of Nauru, the profound and rapid lifestyle changes were caused by wealth from mining of rich phosphate deposits on the island. Findings from further studies in the Pacific islands8, 9, 10, 11, 12 confirmed the high prevalence of diabetes in this region. Furthermore, accumulated evidence from the past 20–30 years shows a rapidly increasing burden of diabetes worldwide.1, 2 Paradoxically, the burden of this so-called western disease, caused by western lifestyles, has the greatest effect on developing countries; more than 80% of the global total of people with diabetes live in these countries.
Section snippets
Recognition of the challenge of diabetes
International health agencies and national governments ignored the rise and rise of diabetes and other non-communicable diseases until quite recently. Funding for the prevention and control of such diseases (including diabetes) was of low priority compared with funding for the control of communicable diseases.13 Against this background, in 2006 the UN General Assembly unanimously passed Resolution 61/225,14 calling for diabetes to be recognised as an international public health challenge. In
Global predictions and patterns
Since 1994, when the first global predictions of a major increase in the number of people with diabetes were published,18 many efforts have been made by both the International Diabetes Federation and WHO19 to regularly update these figures. In 1994, 110 million people worldwide were estimated to have diabetes, and by 2010 the number was predicted to increase to 239 million.18 In 1998, King and colleagues19 reported that 135 million people had diabetes in 1995, and predicted that 300 million
Evidence of increasing prevalence
The study of the occurrence of diabetes over long periods (ie, secular trends) shows the magnitude and speed of the evolution of this epidemic. Although the situation in Nauru was an early warning of the global epidemic, studies in the Indian-Ocean island of Mauritius provide another indicator of the seriousness of the global epidemic.8, 31
Mauritius has a population of 1·3 million, predominantly of Asian-Indian (68%), African (27%), and Chinese (3%) ethnicity. The study in Mauritius covered a
Emergence of type 2 diabetes and prediabetes in youth
The global epidemiology of diabetes is changing. Type 2 diabetes was traditionally thought of as a disorder of middle-aged and elderly people, and almost exclusively as an adult disorder. However, diabetes has become more common, not only in young adults, but also in adolescents and children.2 This change has occurred predominantly in Indigenous populations and other high-prevalence groups.2 Earlier age of onset of type 2 diabetes will affect the future global burden of diabetes and prevention
Epigenetics and the developmental origins of type 2 diabetes
The importance of genetic contributions and their interaction with the environment as key risk determinants of type 2 diabetes has long been accepted.56 In the past 5 years, about 600 genome-wide association studies have examined more than 100 human diseases, uncovering more than 800 genetic variants associated with one or more diseases.57 However, in nearly every case, most of the factors that cause the disease are still unknown, which has led to growing interest in exploration of non-genetic
The cost of diabetes and its complications
The economic effect of diabetes is enormous. In 2010, global health expenditure attributable to diabetes was estimated to be US$376 billion—that is, 12% of all global health expenditure.69 In the USA in 2012, the direct medical cost of diabetes was $176 billion.70 Health-care expenditure attributable to diabetes by cost component for the USA for 2002–12 is shown in figure 3. Expenditure attributable to outpatient medications and supplies increased from about $18 billion to $50 billion,71, 72
Prevention of diabetes: challenges ahead
Strategies for prevention of type 2 diabetes are well developed in some settings, but predominantly in developed nations. Lifestyle intervention has been effective in several countries, but its success depends on uptake of intervention programmes and on compliance.78, 79, 80 These barriers are not trivial, and the strategies used to overcome them might not be practicable in many low-income and middle-income countries. When diabetes prevention programmes developed from successful clinical trials
Conclusions
Type 2 diabetes is one of the great health-care challenges of the 21st century. Over the past two decades, diabetes has become an increasing threat not only in developed but also in developing countries. Diabetes can adversely affect productivity through premature morbidity and mortality, and its effects will probably become even more serious because the disorder is beginning to affect younger generations. The main effect will be in disadvantaged minority ethnic groups and in developing
Search strategy and selection criteria
References (86)
- et al.
Diabetes mellitus in American (Pima) Indians
Lancet
(1971) - et al.
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Lancet
(2012) Non-communicable diseases: 2015 to 2025
Lancet
(2013)- et al.
IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030
Diabetes Res Clin Pract
(2011) - et al.
Global estimates of the prevalence of diabetes for 2010 and 2030
Diabetes Res Clin Pract
(2010) - et al.
Estimation of diabetes prevalence among immigrants from the Middle East in Sweden by using three different data sources
Diabetes Metab
(2008) - et al.
Diabetes prevalence and determinants in Indigenous Australian populations: a systematic review
Diabetes Res Clin Pract
(2011) - et al.
Global complication rates of type 2 diabetes in Indigenous peoples: a comprehensive review
Diabetes Res Clin Pract
(2008) - et al.
Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study
Lancet
(2007) - et al.
Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis
Diabetes Res Clin Pract
(2012)
Glucose tolerance in adults after prenatal exposure to famine
Lancet
Diabetes and associated disorders in Cambodia: two epidemiological surveys
Lancet
Gestational diabetes: the need for a common ground
Lancet
Global healthcare expenditure on diabetes for 2010 and 2030
Diabetes Res Clin Pract
Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study
Lancet
Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study
Am J Prev Med
Early nutrition and adult outcomes: pieces of the puzzle
Lancet
IDF Diabetes Atlas
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Nat Rev Endocrinol
The high prevalence of diabetes mellitus on a Central Pacific Island
Diabetologia
Diabetes running wild
Nature
The Call Girls
High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians
Diabetes
The epidemiology and natural history of NIDDM—lessons from the South Pacific
Diabetes Metab Rev
The Tokelau Island migrant study
Int J Epidemiol
The epidemiology of diabetes in Polynesians and Europeans in New Zealand and the Pacific
N Z Med J
The prevalence of diabetes in the kingdom of Tonga
Diabetes Care
Millennium Development Goals
United Nations Resolution 61/225:World Diabetes Day
Political declaration of the high-level meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases. United Nations
WHO 65th World Health Assembly closes with new global health measures
The NIDDM epidemic: global estimates and projections—a look into the crystal ball
IDF Bulletin
Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections
Diabetes Care
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
Diabetes Care
IDF Diabetes Atlas
Prevalence of diabetes among men and women in China
N Engl J Med
IDF Diabetes Atlas
Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort
Diabetes Care
Management of diabetes in resource-poor settings
Clin Med
Explaining the increase of diabetes prevalence and plasma glucose in Mauritius
Diabetes Care
Diabetes mellitus survey in Shanghai, China
Chin Med J (Engl)
Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities
Diabetologia
Increasing prevalence of type 2 diabetes in Chinese adults in Shanghai
Diabetes Care
Cited by (689)
MIAT LncRNA: A multifunctional key player in non-oncological pathological conditions
2024, Non-coding RNA ResearchRisk of type 2 diabetes and long-term antibiotic use in childhood: Evidence from the UK Biobank
2024, Diabetes Research and Clinical PracticeChinese patent medicine as a complementary and alternative therapy for type 2 diabetes mellitus: A scoping review
2024, Complementary Therapies in MedicineImpedance-based polymer microneedle patch sensor for continuous interstitial fluid glucose monitoring
2024, Biosensors and BioelectronicsAn investigation on antidiabetic competence of Ferula assafoetida mediated AgNPs on diabetic (STZ) induced albino rats
2024, Biocatalysis and Agricultural Biotechnology